These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 9174684
1. Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Lundahl J, Regårdh CG, Edgar B, Johnsson G. Eur J Clin Pharmacol; 1997; 52(2):139-45. PubMed ID: 9174684 [Abstract] [Full Text] [Related]
2. The interaction effect of grapefruit juice is maximal after the first glass. Lundahl JU, Regårdh CG, Edgar B, Johnsson G. Eur J Clin Pharmacol; 1998 Mar; 54(1):75-81. PubMed ID: 9591935 [Abstract] [Full Text] [Related]
3. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Lundahl J, Regårdh CG, Edgar B, Johnsson G. Eur J Clin Pharmacol; 1995 Mar; 49(1-2):61-7. PubMed ID: 8751023 [Abstract] [Full Text] [Related]
4. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD. Clin Pharmacol Ther; 1996 Jul; 60(1):25-33. PubMed ID: 8689808 [Abstract] [Full Text] [Related]
5. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Clin Pharmacol Ther; 1998 Sep; 64(3):248-56. PubMed ID: 9757148 [Abstract] [Full Text] [Related]
6. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. Bailey DG, Arnold JM, Bend JR, Tran LT, Spence JD. Br J Clin Pharmacol; 1995 Aug; 40(2):135-40. PubMed ID: 8562295 [Abstract] [Full Text] [Related]
10. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance. Edgar B, Bailey D, Bergstrand R, Johnsson G, Regårdh CG. Eur J Clin Pharmacol; 1992 Aug; 42(3):313-7. PubMed ID: 1577050 [Abstract] [Full Text] [Related]
11. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Vincent J, Harris SI, Foulds G, Dogolo LC, Willavize S, Friedman HL. Br J Clin Pharmacol; 2000 Nov; 50(5):455-63. PubMed ID: 11069440 [Abstract] [Full Text] [Related]
12. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749 [Abstract] [Full Text] [Related]
14. Grapefruit juice increases oral nimodipine bioavailability. Fuhr U, Maier-Brüggemann A, Blume H, Mück W, Unger S, Kuhlmann J, Huschka C, Zaigler M, Rietbrock S, Staib AH. Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227 [Abstract] [Full Text] [Related]
15. Interaction of citrus juices with felodipine and nifedipine. Bailey DG, Spence JD, Munoz C, Arnold JM. Lancet; 1991 Feb 02; 337(8736):268-9. PubMed ID: 1671113 [Abstract] [Full Text] [Related]
16. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers. Josefsson M, Zackrisson AL, Ahlner J. Eur J Clin Pharmacol; 1996 Feb 02; 51(2):189-93. PubMed ID: 8911887 [Abstract] [Full Text] [Related]
17. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG. Clin Pharmacol Ther; 2002 Sep 02; 72(3):247-55. PubMed ID: 12235445 [Abstract] [Full Text] [Related]
18. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB. J Clin Invest; 1997 May 15; 99(10):2545-53. PubMed ID: 9153299 [Abstract] [Full Text] [Related]
19. Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects. Hashimoto K, Shirafuji T, Sekino H, Matsuoka O, Sekino H, Onnagawa O, Okamoto T, Kudo S, Azuma J. Eur J Clin Pharmacol; 1998 May 15; 54(9-10):753-60. PubMed ID: 9923580 [Abstract] [Full Text] [Related]